October 2014 AHPA Report

AHPA Reports

AHPA's monthly newsletter. Members log in to access issues of the AHPA Report.

October 2014 AHPA Report

Published: Thursday, October 2, 2014

Special Topics:

The importance of reliable product chemistry data: a case study by Dallas Wait, Ph.D., Gradient

And Inside AHPA:

  • AHPA issues cannabis oversight recommendations for regulators
  • AHPA grows more than 12% in 2014
  • AHPA president provides supplement regulation compliance strategies
  • AHPA Updates for September 2014
  • AHPA-ERB Foundation forms American Ginseng Advisory Panel
  • New members
  • Savings opportunities for AHPA members
  • AHPA in the news


FDA inspecting, warning, enjoining, prosecuting distributors of drug-spiked ‘supplements’ by Anthony L. Young, Kleinfeld, Kaplan & Becker LLP and AHPA General Counsel

2020 Annual Fund Sponsors


AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.